myeloMATCH Archives

Filter by
Categories
Tags
Authors
Show all

All
AACR
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia
Acute myeloid leukemia (AML)
Acute promyelocytic leukemia
Adolescents and young adults
Advanced melanoma
Advanced practice providers
Advocacy
Anal cancer
ARPA-H
Artificial intelligence (AI)
ASCO
ASTRO
Awards
AYA cancer
B-cell lymphoma
Big data
Biostatistics
Bladder cancer
Blood cancer
Blood cancers
Brain cancer
Breast cancer
Cancer
Cancer care delivery research
Cancer control
Cancer research
Cancer research policy
Cancer screening
Cancer surveillance
Cardiotoxicity
CBPF
Chemoimmunotherapy
Chemotherapy
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Chronic myeloid leukemia
Clinical trial
Clinical trials
Colorectal cancer
Colorectal liver metastases
ComboMATCH
Comis Symposium
Communication
Community oncology
Cooperative Group cancer research
Correlative science
COVID-19
CT scans
Data science
DCIS
De-escalation
Deep learning
DEI
Developmental therapeutics
Diversity
EGFR
Engineering
ESMO
Esophagus cancer
Ethics
Federally-funded cancer research
Financial hardship
Gallbladder cancer
Gastric cancer
Gastroesophageal junction cancer
GBM
Gender equity
Genetic testing
Genomics
Geriatric oncology
GI cancer
Glioblastoma
Glioma
GM-CSF
Green tea catechins
Group Meeting
GU cancer
Head and neck cancer
Head and neck squamous cell carcinoma
health care
Health care administration
Health equity
Hematologic malignancies
Hematology
Hepatic arterial infusion
HER2-positive breast cancer
Hormone therapy
Imaging
Immune checkpoint inhibitors
Immunotherapy
In memory
Institution Evaluation
Just-in-time clinical trials
Kidney cancer
Language
Leadership
Leukemia
Liver cancer
Lung cancer
Lung inflammation
Lymphoblastic lymphoma
Lymphoma
Mammography
Mantle cell lymphoma
Meetings
Melanoma
Membership
Mentorship
Merkel cell carcinoma
Mesothelioma
Misinformation
Multiple myeloma
Myelodysplastic neoplasms
Myelodysplastic syndromes
Myeloid malignancies
Myeloma
myeloMATCH
National Cancer Act
Natural language processing
NCI
NCI-Designated Comprehensive Cancer Centers
NCI-MATCH
NCORP
NCTN Grant
Neuroendocrine tumors
NIH
NIPEC
Non-Hodgkin lymphoma
Non-small cell lung cancer
NSCLC
Older adults
Ovarian cancer
Pancreatic cancer
Pancreatic cyst
Pancreatic cysts
Pancreatic NETs
Pathology
Patient care
Patient registry
Patient reported outcomes (PROs)
Patient-reported outcomes
Penile cancer
Peripheral neuropathy
Personalized medicine
Personalized screening
Pneumonitis
Policy
Pragmatic clinical trials
Precision medicine
Precision oncology
PrECOG
Prevention
Prostate cancer
Proteasome inhibitors
Public-private partnerships
Publications
Quality of life
Racism
Radiation
Radiology
Rare disease
Real-world data
Recurrence
Renal cell
Renal cell carcinoma
Reproductive health
Research results
Retroperitoneal sarcoma
Sarcoma
Scholarship
Sexuality
Side effects
Smoking cessation
Smoldering multiple myeloma
Social determinants of health
Social genomics
Stomach cancer
Survivorship
Symptom control
Symptom management
Symptom science
Targeted therapy
Throat cancer
Thyroid cancer
TMIST
Tobacco cessation
Translational research
Urinary tract cancer
Vaccination
Women in oncology
Young investigators

December 19, 2025

December 19, 2025

Categories

News in Brief

News in Brief, December 2025

Timely updates on research leaders, presentations at medical meetings and more

November 25, 2024

Categories

News in Brief

News in Brief, November 2024

June 11, 2024

June 11, 2024

Categories

From the Co-Chairs

From the Co-Chairs, June 2024

A Spring Group Meeting recap; a milestone for TMIST; a new myeloMATCH treatment trial

June 11, 2024

Categories

Active Clinical Trials

Now Enrolling: myeloMATCH Treatment Trial MM1OA-EA02 for Older Patients with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia

This phase 2 study is testing two variations of the triplet combination of azacitidine, venetoclax, and gilteritinib compared to standard therapy